News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Conference News TCT 2016 ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions L.A. McKeown November 07, 2016
News Conference News Watchman, Amulet LAA Closure Devices Carry Low Complication Rates Todd Neale November 04, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
Presentation TCT 2016 AMULET OBSERVATIONAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David Hildick-Smith November 02, 2016
Presentation TCT 2016 WATCHMAN US POST-APPROVAL STUDY: Multicenter, Prospective, Registry Results With a Left Atrial Appendage Closure Device for Stroke Prevention in Patients With Atrial Fibrillation Presenter: Martin B. Leon, Louis A. Cannon, David R. Holmes Jr. November 02, 2016
News Conference News TCT 2016 Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making Yael L. Maxwell November 02, 2016
Presentation TCT 2016 ILLUMENATE U.S.: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs an Uncoated Balloon for Treatment of Diseased Superficial Femoral and Popliteal Arteries Presenter: Martin B. Leon, Louis A. Cannon, Sean P. Lyden November 02, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials Presenter: Helene Eltchaninoff, Neal S. Kleiman, Andreas Baumbach November 01, 2016
Presentation TCT 2016 What Should Be the Next Series of Clinical Trials in PFO Closure? Presenter: Eustaquio Maria Onorato, Richard Smalling, John D. Carroll November 01, 2016
Presentation TCT 2016 What Do the Randomized Clinical Trials Tell Us and How Did the FDA Respond? Presenter: John D. Carroll, Christian Spies November 01, 2016
Presentation TCT 2016 To Pretreat or Not to Pretreat? The DUBIUS Trial Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini November 01, 2016
Presentation TCT 2016 Accurate: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Helge Möllmann November 01, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
Presentation TCT 2016 Direct Flow: Design Features, Special Attributes, and Clinical Trial Program Presenter: Eberhard Grube, James B. Hermiller Jr., Azeem Latib November 01, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016